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barriers and facilitators that may affect the integration and scale-up of
evidence-based safer conception programs from high-resource coun-
tries. Furthermore, these implementation studies will identify the
adaptable program components to ensure cost-effective and sustain-
able services in low-resource settings. From a reproductive justice
perspective, HIV prevention programs should include accessible
safer conception services for HIV-affected couples. Financial support
needed to achieve this goal may require commitment from founda-
tions and national and global organizations to strengthen HIV preven-
tion efforts and assure the reproductive rights of HIV-affected
couples.
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Obstetric hemorrhage, the leading cause of maternal mortality, ac-
counts for up to 44% of maternal deaths in regions of West and East
Sub-Saharan Africa; 26% of these deaths can be attributed to the paucity
of donated blood available for emergency transfusions [1]. This situation
complicates the efforts of clinicians to treat ruptured ectopic pregnancy,
which is the largest contributor tomortality in the first trimester. Auto-
transfusion is a life-saving intraoperative blood salvage procedure that
is routinely performed using automated blood salvage devices in
high-income countries [2]. Such devices are inappropriate for
low-income countries owing to their cost and complexity (i.e. difficult
to maintain), among other factors [3]. Furthermore, effective manual
blood salvage solutions including the soup ladle method [4] and the
Tanguieta funnel [3] developed for use in low-income countries can
be labor intensive and require numerous disposables.
Design ethnography studies including clinical observations and in-
terviews were conducted primarily at Komofo Anokye Teaching
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Hospital, Kumasi, Ghana, and several nearby district hospitals during
July and August 2010. The aim was to identify and understand the
need for a simple, low-cost, closed-system and mechanical alterna-
tive for use during an intraoperative blood salvage procedure follow-
ing a ruptured ectopic pregnancy. User requirements and engineering
specifications were determined through interviews with Ghanaian
clinicians, nurses, and biomedical technicians; observations;
benchmarking; literature review; and surveys. Solution concepts
were generated using functional decomposition and brainstorming
techniques.
The selected concept resembled an oversized syringe that served
as a self-contained, mechanically powered system with a series of
one-way valves, inline filters, and an outlet valve connected to a
standard blood bag (Fig. 1). The instrument is operated by inserting
the nozzle into the pooling blood present within the surgically
opened abdominal cavity. Pulling back on the plunger draws the
pooled blood inside, passing it through a 170-μm filter (Fig. 1b)
and into the barrel. The nozzle is typically positioned within the
abdominal cavity to avoid regions with large clots. However, clots
entering the device accumulate in the hollowed nozzle. Pushing
down on the plunger then forces the blood to exit through a
one-way valve that can be connected to a standard blood bag. The
operation repeats until all of the blood intended for transfusion is
processed. The current version of the concept solution includes a
disposable filter (Fig. 1c) that is replaced between each patient use.
Fig. 1. (A) Gross specimens of recurrent abdominopelvic disease, showing
well-circumscribed, nodular lesions. (B) Pathologic evaluation of abdominopelvic
tumor nodules (hematoxylin-eosin x40) showing spindle cells with occasionally en-
larged nuclei with mild atypia. No necrosis or mitoses identified consistent with LGL.
Inset showing diffuse strong positive nuclear staining for estrogen receptor. Progester-
one receptor staining was negative (not shown).
The other components of the device can be sterilized in an autoclave.
Although the filter medium is autoclavable, the filter’s pore size
makes it difficult to clean, thereby increasing the likelihood of
cross-contamination. The prototype (Fig. 1a) weighs approximately
0.5 kg with overall dimensions of 33 x 11 x 7.5 cm and features
transparent components to allow observation of the blood. Each
filter cartridge has 170-μm pores and a surface area of 137 cm2.
The nozzle opens to replace the filter by twisting a four-prong
bayonet closure (Fig. 1d).
Pre-clinical studies were performed to evaluate the prototype. In-
stitutional Review Board approval was not obtained for the pre-clini-
cal studies because the studies did not involve human subjects.
Simulated blood was used to confirm processing rates of 1.6−2.6 L/
min. Five test samples of reconstituted human blood (approximately
500 mL packed red blood cells and ABO-compatible thawed plasma,
approximately 50% hematocrit) were used to assess the effects of pro-
cessing on hematocrit and plasma hemoglobin levels. The samples
showed no evidence of hemolysis or changes in hematocrit or hemo-
globin. The concept was also well received by Ghanaian clinicians fol-
lowing informal usability studies. Although Ghanaian stakeholders
originally requested a more cost-effective automated blood salvage
device, design ethnography studies revealed challenges associated
with maintaining such systems in low-income countries.
This concept solution has the potential to address the need for a
low-cost, mechanical device to treat ruptured ectopic pregnancy. Fu-
ture work includes conducting additional pre-clinical studies,
obtaining regulatory approval, performing clinical trials in Ghana,
and iterating the design to further reduce the cost of the device (tar-
get US $1 per use). Simplicity of design as well as intuitive design fea-
tures should increase the likelihood of minimal required training and
adoption by clinics lacking a reliable power supply or the funds to
purchase and maintain complex equipment.
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